Indivior Pharmaceuticals INDV
NASDAQ INDV
$35.71 +0.33 (+0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) Other Non Operating Income (2026)

Updated

Indivior Pharmaceuticals (INDV) recorded Other Non Operating Income of -$18 million in Q1 2026.

Analysis

Indivior Pharmaceuticals (INDV) Other Non Operating Income (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Indivior Pharmaceuticals 4.18 Bn 3.14 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.00 Mn
API Access

Indivior Pharmaceuticals Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=INDV&period=max&api_key=YOUR_API_KEY